For a long time, three major multinational medical device manufacturers (referred to as GPS), General Motors (GE), Philips (Siemens), have controlled 70% of high-end medical equipment in the Chinese market. On the one hand, GPS products have been widely welcomed by the market because of their high technical content, strong innovation ability and perfect service chain. On the other hand, GPS products are overpriced and market share is too high, and they have been questioned for suspected industry monopoly and profiteering. Operating. According to the Prospective Industry Research Institute's "2014-2018 China Medical Device Industry Market Preview and Investment Forecast Analysis Report", in China's medical device field, about 80% of the CT market, 90% of the ultrasonic instrument market, and 85% of the inspection instruments. The market, 90% of magnetic resonance equipment, 90% of the ECG market, 80% of the high-end monitor market, and 90% of the high-end physiological recorder market are monopolized by foreign companies. In some areas, the coverage of imported equipment can reach 100%. To encourage the development of domestic medical devices. Since 2014, the state's top management has repeatedly proposed the development of domestic medical devices. The “Regulations on the Supervision and Administration of Medical Devices†and the “Special Approval Procedure for Innovative Medical Devices†have all contributed to the development of domestically produced devices. In August 2014, at the conference on promoting the development and application of domestic medical equipment jointly organized by the National Health Planning Commission and the Ministry of Industry and Information Technology, the upgrade of domestic medical equipment once again became the focus. Miao Wei, Minister of the Ministry of Industry and Information Technology, said that in order to promote the development of the domestic medical equipment industry, an incentive mechanism for active use of domestic medical equipment will be established. Li Bin, director of the National Health Planning Commission, said that it will focus on promoting the use of domestic medical equipment in the top three hospitals. In the policy-oriented Chinese medical market, how will the foreign-invested medical enterprise GE lay out and take the road of the future? On May 16, GE Global Senior Vice President and GE Greater China President and CEO Duan Xiaoyu told reporters that companies can't rely on government support to maintain competitiveness, products are good, service is good, or the market has the final say, GE Have confidence in their own market competitive advantage. Enterprises cannot rely on government support to remain competitive Reporter: For a long time, foreign brands have always been in a dominant position in the field of medical devices. Now, the Chinese government encourages the development of domestic brands of medical devices. How do you see the impact of this change on industry competition and GE Healthcare? Duan Xiaowei: Recently, I have often asked friends from the media about me. Many of my questions about domestic and foreign brands are very simple. I think this is also a view that continues on behalf of GE. First, competition is a good thing. The ultimate benefit of competition is the consumer and the ultimate customer. Second, any enterprise must maintain a sustainable win in the market. It must be customer-centered. Whether the product is good or not, the service is good. The market and the customer have the final say. Any enterprise must maintain sustainable competitiveness. And innovation, this is the most fundamental from the perspective of GE. GE's long-term commitment to the entire culture and innovation, the starting point is to serve our end customer market and serve our customers. Another point to point out is that any company that wants to maintain sustainable competitiveness cannot rely on any short-term government support. It must go to the market to exercise. I believe that the vision of many Chinese companies today is not just in China. There is support in China, competition in the international market depends on itself, whether the product is excellent, whether the service is excellent, and whether there is competition. Reporter: More and more pharmaceutical foreign companies are taking the localization road and resetting their production bases and innovation centers in China to gain more government support and human resources advantages. Between globalization and localization, you think How to balance? Duan Xiaowei: For GE, we have been positioning global companies. We can look at GE's management team, which is basically a localized team. We are confident in our competitive advantage in the market. We have international funding, and GE's global sales of 7% to 8% per year are invested in research and development. GE has the most advanced management technology and process management in the world. GE is known as the manager of the Whampoa Military Academy. Many of the world's top 500 CEOs are from GE. We have the support of a strong technical background, which is the advantage of global resources. GE Healthcare is a very localized company in China. The localization of talents determines the localization of decision-making. At the same time, GE Healthcare has been developing products and products in the Chinese market very fast in the past four years. From this perspective, we have both the advantages of globalization and the advantages of localization. We are very confident in winning the competition in the Chinese market. I believe that the whole of China needs to develop. In fact, we don't have to be too particular about whether it is a state-owned enterprise, a private enterprise, a private enterprise or a foreign enterprise. The final thing to look at is whether it can bring benefits to the entire market. Organic cornstarch is the lightest and most versatile starch. It is made from organic corn through multiple processes. Corn starch contains linoleic acid and vitamin E, which can lower cholesterol levels in the body, thereby reducing the occurrence of arteriosclerosis. It contains more calcium and iron, which can prevent high blood pressure and coronary heart disease. It also contains trace element selenium, which can accelerate the decomposition of oxides in the body and inhibit malignant tumors. Corn Starch,Organic Cornstarch,Organic Corn Starch,Organic Cornstarch Powder Organicway (xi'an) Food Ingredients Inc. , https://www.organicwayince.com